SCHEMBL24372958

SCHEMBL24372958

Cc1ccc2c(c1)C1(c3cc(F)ccc3-2)c2ccccc2-c2cccc(-c3ccccc3)c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 10/20 0.43
ACHE P22303 1/20 0.35
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
ALOX15 P16050 1/20 0.34
NFKB1 P19838 1/20 0.34
CASP1 P29466 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
KMT2A Q03164 1/20 0.34
RELA Q04206 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
PSMB5 P28074 1/20 0.33
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26035743 0.92 PDK2 (0.45) PDK2ACHEMAPTSMN1; SMN2NPC1
SCHEMBL21926765 0.88 PDK2 (0.37) PDK2ACHEMAPTSMN1; SMN2MEN1
SCHEMBL19001663 0.85 PDK2 (0.53) PDK2ACHEESR1ESR2
SCHEMBL21928665 0.82 PDK2 (0.40) PDK2
SCHEMBL20618826 0.82 PDK2 (0.40) PDK2MAPTSMN1; SMN2MEN1NPC1
SCHEMBL26035276 0.81 PDK2 (0.42) PDK2ACHE
SCHEMBL20618646 0.81 PDK2 (0.42) PDK2ESR1ESR2
SCHEMBL20618653 0.81 PDK2 (0.45) PDK2
SCHEMBL21925960 0.80 PDK2 (0.45) PDK2NPSR1ESR2
SCHEMBL21928684 0.79 PDK2 (0.36) PDK2MAPTSMN1; SMN2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS MERCK PATENT GMBH (DE) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS L1CAM, EPCAM, SELPLG PDK2 4119/4885ACHE 1460/4885MAPT 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.